Abstract:Objective: To investigate the clinical value of T lymphocyte subsets and NK cells in peripheral blood of patients with high-risk HPV infection and different cervical lesions. Methods: CD3(+), CD4(+), CD8(+) lymphocyte subsets and CD16(+) CD56(+) cells in specimens of peripheral blood of 212 healthy control and 2167 patients with high-risk HPV infection and different cervical lesions were detected by flow cytometry. Results: Different patients with highrisk HPV infection in cervical lesions, CD4(+), CD16(+) CD56(+) cells and the numbers of CD4(+)/CD8(+) ratio were lower than those in the healthy control group, and with the severity of lesions increment to gradually reduce (P<0.01), while CD8(+) cell numbers were higher than those in the healthy control group, and with increasing severity lesions gradually increased (P<0.01). The cellular immune function of all patients with cervical squamous cell carcinoma were significantly lower than those in healthy control group, and with the severity of lesions increment to gradually reduce. The cellular immune function of patients of cervical squamous cell carcinoma with lymph node metastasis were significantly lower than that in patients without lymph node metastasis (P<0.01), and in patients with well differentiated, poorly differentiated and moderately differentiated of cervical squamous cell carcinoma group were no difference between them (P>0.05). But CD4(+), CD8(+) cells and CD4(+)/CD8(+) ratio of patients with low differentiation are significantly lower than patients with well-differentiated. The number of cells of CD4(+), CD16(+) CD56(+) reducing and CD4(+)/CD8(+) ratio decreased were negative correlated to clinical stages of cervical squamous cell carcinoma, namely were decreased with the increasing of clinical stages (P<0.01). The number of CD8(+) cell was positive correlated with clinical stages of cervical squamous cell carcinoma (P<0.01). Conclusion: The cellular immune function of the patients with high-risk HPV infection and different cervical lesions is lower and especially even worse in patients with cervical squamous cell carcinoma and with advanced clinical stages. Detecting T lymphocyte subsets and NK immune cells can be used to monitor cellular immune function of patients with cervical squamous cell carcinoma and to estimate prognosis and provide reference for clinical treatment.

Analysis of T-lymphocytes subgroups and NK cells in peripheral blood of patients with digesting systemic cancer

Analysis of NK/T and Treg cell in peripheral blood of patients with different malignancies during the chemotherapy

Detection of T Lymphocyte Subset and NK Cell in Peripheral Blood of Patients with Colorectal Cancer

Analysis on the Change of Peripheral Blood T Lymphocyte Subsets Before and after Chemotherapy in Patients with Non-Small Cell Lung Cancer

THE LEVEL AND SIGNIFICANCE OF T LYMPHOCYTE SUB-GROUP IN PERIPHERAL BLOOD IN PATIENTS WITH CANCER

[Changes in the proportion of lymphocyte subsets and the expression of surface receptors in peripheral blood of patients with colorectal cancer]

Clinical Significance of Peripheral Blood and Tumor Tissue Lymphocyte Subsets in Cervical Cancer Patients

Detection of T Cell Subsets in Peripheral Blood of Cervical Cancer and Its Clinical Significance

Distribution of Natural Killer Cells and T-Lymphocyte Subsets in Peripheral Blood, Gallbladder Cancer and Surrounding Tissue

Analysis of CD4+T, CD8+T and Regulatory T Cells in Peripheral Blood from Pancreatic Cancer Patients

Study on Peripheral Blood T Lymphocyte Subsets of Patients with Lung Cancer and Lung Infection

Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression

The Profile of CD4+CD25+ T Regulatory Lymphocytes Subpopulation in Patients with Cancer by Flow Cytometry

Diagnostic and prognostic value of the peripheral natural killer cell levels in gastric cancer

The analysis of peripheral blood lymphocyte subgroup in patients with esophageal cancer before and after treatment

The detection and clinical significance of CD4- CD8- T cells in the peripheral blood of patients with pancreatic carcinoma

Study on quantity and function of peripheral blood NK cell subsets in primary liver cancer

Observation of Changes in Peripheral Lymphocyte Subsets by Flow Cytometry in Patients with Non-Small Cell Lung Cancer Treated with Paclitaxel and Cisplatin

Study on the subset of T lymphocyte and CD4 + CD25 + regulatory cells in peripheral blood in patients with gastric cancer

Detection of T Lymphocyte Subsets in the Peripheral Blood of Patients with Advanced Lung Adenocarcinoma

The Clinical Value Of T Lymphocyte Subsets And Nk Cells In Peripheral Blood Of Patients With High-Risk Hpv Infection And Different Cervical Lesions